Organoclick Ab Stock Price To Earning
| ORGC Stock | SEK 2.65 0.04 1.53% |
Organoclick AB fundamentals help investors to digest information that contributes to Organoclick's financial success or failures. It also enables traders to predict the movement of Organoclick Stock. The fundamental analysis module provides a way to measure Organoclick's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organoclick stock.
Organoclick |
Organoclick AB Company Price To Earning Analysis
Organoclick's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Organoclick Price To Earning | (17.42) X |
Most of Organoclick's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organoclick AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Organoclick AB has a Price To Earning of -17.42 times. This is 116.62% lower than that of the Basic Materials sector and 153.87% lower than that of the Specialty Chemicals industry. The price to earning for all Sweden stocks is 160.65% higher than that of the company.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Organoclick Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.32) % | |||
| Operating Margin | (0.27) % | |||
| Current Valuation | 352.06 M | |||
| Shares Outstanding | 97.95 M | |||
| Shares Owned By Insiders | 35.49 % | |||
| Shares Owned By Institutions | 22.34 % | |||
| Price To Earning | (17.42) X | |||
| Price To Book | 3.99 X | |||
| Price To Sales | 3.07 X | |||
| Revenue | 110.06 M | |||
| Gross Profit | 18.51 M | |||
| EBITDA | (14.57 M) | |||
| Net Income | (32.69 M) | |||
| Cash And Equivalents | 34.25 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 24.85 M | |||
| Debt To Equity | 198.40 % | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | 0.81 X | |||
| Cash Flow From Operations | (37.69 M) | |||
| Earnings Per Share | (0.33) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 48 | |||
| Beta | 0.96 | |||
| Market Capitalization | 365.11 M | |||
| Total Asset | 188.39 M | |||
| Retained Earnings | (76 M) | |||
| Working Capital | 30 M | |||
| Current Asset | 52 M | |||
| Current Liabilities | 22 M | |||
| Z Score | 8.4 | |||
| Net Asset | 188.39 M |
About Organoclick Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Organoclick AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organoclick using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organoclick AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.